GlassScriptPhysician profile
Christopher Thomas Bednarek
NPI 1144512161
$5,877.72
in general payments reported to CMS, 2019-2025
39 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what 79% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $154 · 2021: $572 · 2022: $1,352 · 2023: $1,114 · 2024: $977 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,473.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $810.72 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Abbott Laboratories | $750.70 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $620.34 | 2020-2024 | Senza |
| Globus Medical, INC. | $563.49 | 2025 | Senza |
| Vertos Medical, INC. | $554.96 | 2022-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $528.11 | 2019-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $300.12 | 2019-2025 | Relistor |
| Saluda Medical Americas, INC. | $245.59 | 2024 | Evoke |
| Boston Scientific Corporation | $208.78 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Kowa Pharmaceuticals America, INC. | $154.69 | 2022-2023 | Seglentis |
| Allergan, INC. | $119.40 | 2019-2021 | |
| Medtronic, INC. | $111.87 | 2021-2023 | Intellis Adaptivestim |
| Pfizer INC. | $91.41 | 2019-2025 | |
| Relievant Medsystems, INC. | $76.63 | 2023 | Intracept |
| Averitas Pharma INC. | $73.66 | 2023-2025 | Qutenza |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $65.00 | 2023 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $61.17 | 2019-2023 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $54.56 | 2024-2025 | Journavx |
| Si-Bone, INC. | $47.18 | 2022 | |
| International Rehabilitative Sciences, INC | $43.68 | 2024 | Rs 4i Plus Sequential Stimulator |
| Tonix Medicines, INC. | $38.57 | 2025 | Tonmya |
| Electronic Waveform Lab, INC. | $31.78 | 2022-2025 | |
| Spinal Simplicity, LLC | $25.96 | 2023 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $25.60 | 2020 | |
| Lundbeck LLC | $25.60 | 2022 | |
| Fidia Pharma USA INC. | $24.87 | 2024 | Hyalgan, Hymovis, Triluron |
| Almatica Pharma LLC | $23.67 | 2022 | |
| Daiichi Sankyo INC. | $22.86 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.05 | 2019 | |
| Kaleo, INC. | $19.57 | 2019 | |
| Amgen INC. | $19.19 | 2025 | Krystexxa |
| Zyla Life Sciences, INC. | $19.10 | 2020 | |
| Curonix LLC | $16.16 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $15.93 | 2019 | |
| Nalu Medical, INC. | $14.57 | 2025 | Nalu Neurostimulation System |
| Valinor Pharma, LLC | $13.50 | 2025 | Movantik |
| Arbor Pharmaceuticals, INC. | $12.89 | 2019 | |
| Acacia Pharma INC | $12.17 | 2021 | |
| Biodelivery Sciences International, INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bednarek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.